Demonstrator Lab project GlucoEasy wins NWO Open Mind funding of € 50,000
November 13, 2018GlucoEasy has won the NWO Open Mind funding of € 50,000. The Open Mind grants are awarded by NWO to technologies with a surprisingly societal application.
Measure glucose, but comfortably
Diabetics should no longer have to measure their glucose levels by pricking blood. It can perhaps be a lot more comfortable, for example by measuring glucose levels in sweat. Dr. Elizabeth von Hauff, associated with the Vrije Universiteit Amsterdam, has won an Open Mind grant for that idea. Von Hauff proposes to combine two existing measurement techniques into a new, highly sensitive glucose measurer that can continuously measure without pricking. This new technique will not suffer from fluctuations in pH, temperature and composition – and that makes it suitable to measure glucose in something other than blood. GlucoEasy is one of the projects of Demonstrator Lab.
Open Mind financing
Five bold research proposals have received Open Mind funding of € 50,000 from NWO. The grants were awarded during Teknowlogy, NOW’s innovation congress. The winning proposals were appointed by a jury, led by Ionica Smeets. NWO awards five Open Mind grants of € 50,000 for socially relevant research outside the beaten track.
More news
Alumni Joint Master Entrepreneurship (UvA/VU) often pursue entrepreneurial careers
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]
News
Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]
News
2016 AMSIA winner receives CE Mark for non-radioactive tumor localization system
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]
News